Accueil › Cancer du poumon › Illinois › Evanston
Essais cliniques pour Cancer du poumon à Evanston, IL
19 études pour Cancer du poumon recherchent des participants dans et autour de Evanston (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
- et 1 autres
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Recrutement en coursPhase 3
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Recrutement en coursPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recrutement en coursPhase 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Illinois Cancer Specialists, Niles · à 6 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Recrutement en coursPhase 3
- Illinois Cancer Specialists, Niles · à 6 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recrutement en coursPhase 3
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
A Registry for People With Lung Cancer
Recrutement en coursÉtude observationnelle
- Endeavor Health, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Recrutement en coursPhase 3
- Illinois Cancer Specialists, Niles · à 6 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 2
- Advocate Aurora Health, Park Ridge · à 8 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · à 5 mi
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Recrutement en coursVolontaires sains bienvenus
- Northwestern University, Evanston
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recrutement en coursÉtude observationnelle
- Northshore University Health System, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recrutement en coursÉtude observationnelle
- Advocate Lutheran General Hospital, Park Ridge · à 8 mi
Essais pour Cancer du poumon dans d'autres villes
- Houston, TX78 études
- Boston, MA62 études
- New York City, NY60 études
- Los Angeles, CA45 études
- Washington, DC41 études
- Arlington, VA41 études
- Chicago, IL41 études
- Nashville, TN40 études
- Baltimore, MD40 études
- St. Louis, MO39 études
- Columbus, OH37 études
- Philadelphia, PA36 études
Autres études à Evanston
- Cancer du poumon non à petites cellules22 études
- Cancer du sein13 études
- Leucémie aiguë myéloïde11 études
- Obésité11 études
- Cancer colorectal10 études
- Cancer (tous types)9 études
- Surpoids9 études
- Colite ulcéreuse9 études
- Cancer de la prostate9 études
- Maladie de Crohn9 études
- Insuffisance cardiaque8 études
- Fibrillation auriculaire8 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.